BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18924328)

  • 1. [Helicobacter pylori infection: what to do after first intent treatment failure?].
    Delchier JC
    Rev Prat; 2008 Sep; 58(13):1442-4. PubMed ID: 18924328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Failure of Helicobacter pylori eradication--suggestions for further therapy].
    Prónai L; Tulassay Z
    Orv Hetil; 2003 Jun; 144(26):1299-302. PubMed ID: 12894674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori "rescue" therapy after failure of two eradication treatments.
    Gisbert JP; Pajares JM
    Helicobacter; 2005 Oct; 10(5):363-72. PubMed ID: 16181345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [How to treat after Helicobacter pylori eradication failure?].
    Bruley des Varannes S
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):478-83. PubMed ID: 12700506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures.
    Gisbert JP; Gisbert JL; Marcos S; Moreno-Otero R; Pajares JM
    Aliment Pharmacol Ther; 2006 Nov; 24(10):1469-74. PubMed ID: 17032282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attitude facing a patient suffering from Helicobacter pylori infection resistant to a triple therapy.
    Gisbert JP; Pajares JM
    Rev Esp Enferm Dig; 2003 Mar; 95(3):220-8, 210-19. PubMed ID: 12760711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of quadruple regimen of clarithromycin added to metronidazole-containing triple therapy against Helicobacter pylori infection following clarithromycin-containing triple-therapy failure.
    Ueki N; Miyake K; Kusunoki M; Shindo T; Kawagoe T; Futagami S; Tsukui T; Inagaki H; Sakamoto C
    Helicobacter; 2009 Apr; 14(2):91-9. PubMed ID: 19298336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variables influencing outcome of Helicobacter pylori eradication therapy in South China.
    Cai W; Zhou L; Ren W; Deng L; Yu M
    Helicobacter; 2009 Oct; 14(5):91-6. PubMed ID: 19751433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Helicobacter pylori.
    Wolle K; Malfertheiner P
    Best Pract Res Clin Gastroenterol; 2007; 21(2):315-24. PubMed ID: 17382279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rescue therapy after Helicobacter pylori eradication failure].
    Gisbert JP
    Gastroenterol Hepatol; 2011 Feb; 34(2):89-99. PubMed ID: 21371619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to proceed in Helicobacter pylori-positive chronic gastritis refractory to first- and second-line eradication therapy.
    Vaira D; Ricci C; Lanzini A; Perna F; Romano A; Corinaldesi R
    Dig Dis; 2007; 25(3):203-5. PubMed ID: 17827940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levofloxacin-containing triple therapy to eradicate the persistent H. pylori after a failed conventional triple therapy.
    Cheng HC; Chang WL; Chen WY; Yang HB; Wu JJ; Sheu BS
    Helicobacter; 2007 Aug; 12(4):359-63. PubMed ID: 17669110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori eradication therapy success regarding different treatment period based on clarithromycin or metronidazole triple-therapy regimens.
    Filipec Kanizaj T; Katicic M; Skurla B; Ticak M; Plecko V; Kalenic S
    Helicobacter; 2009 Feb; 14(1):29-35. PubMed ID: 19191893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates.
    Romano M; Iovene MR; Russo MI; Rocco A; Salerno R; Cozzolino D; Pilloni AP; Tufano MA; Vaira D; Nardone G
    J Clin Pathol; 2008 Oct; 61(10):1112-5. PubMed ID: 18755715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection.
    Navarro-Jarabo JM; Fernández N; Sousa FL; Cabrera E; Castro M; Ramírez LM; Rivera R; Ubiña E; Vera F; Méndez I; Rivas-Ruiz F; Moreno JL; Perea-Milla E
    BMC Gastroenterol; 2007 Jul; 7():31. PubMed ID: 17651479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen.
    Rokkas T; Sechopoulos P; Robotis I; Margantinis G; Pistiolas D
    Am J Gastroenterol; 2009 Jan; 104(1):21-5. PubMed ID: 19098844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Helicobacter pylori infection.
    O'Connor A; Gisbert J; O'Morain C
    Helicobacter; 2009 Sep; 14 Suppl 1():46-51. PubMed ID: 19712168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori diagnosis and management.
    Vilaichone RK; Mahachai V; Graham DY
    Gastroenterol Clin North Am; 2006 Jun; 35(2):229-47. PubMed ID: 16880064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
    Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS
    Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Helicobacter pylori.
    Egan BJ; Katicic M; O'Connor HJ; O'Morain CA
    Helicobacter; 2007 Oct; 12 Suppl 1():31-7. PubMed ID: 17727458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.